Many blockchain projects are targeting the data market, but a vast portion of them are developing products in a reactive strategy to market demand. Teams that noticed that certain sectors, like IoT, had developed into a massive market reliant on data for advancement developed products to fulfill that demand. The effort to fulfill that demand via decentralizing data sourcing is a great opportunity, but a reactive one.

There is nothing wrong with reactive product development as, in fact, that is what most entrepreneurs do. But the ideas that truly push the bounds of innovation are led by a proactive product development mindset. A new blockchain project, Shivom, aims to create a genomic data marketplace where can sell their genomic data to any entity.

A Proactive Approach

It's important that blockchain projects start taking proactive product development strategies as the sheer factor of being “on the blockchain” is becoming a redundant differentiation. This once innovative industry has given rise to ICOs that provide funding to challenging projects and that should give entrepreneurial teams the confidence to approach new concepts like Shivom.

The healthcare industry has recently adopted increased reliance on data to optimize its operations. Data is making its way into drug development and patient care. However, the usage of genomic data, despite being an extremely valuable prospect, is quite limited.

Shivom is taking a proactive approach to providing a supply of a particular type of data that does not have a developed market yet. But the reasoning for that is that acquiring genomic data is quite challenging at present. Shivom is one of the first companies to even consider developing a genomic data product. However, given the massive utility the healthcare industry could derive from genomic data, the genomic data supply could easily be swept by major pharmaceuticals and research institutes.

Perks of Being Proactive

By being one of the very few companies in the genomic data market, Shivom immediately becomes a key player affecting a category of data that holds vital importance to the advancement of the healthcare industry. Shivom’s highly qualified team has observed the massive potential genomic data could have in the market, but they also observed that the extremely limited supply of genomic data makes it tough to utilize.

By providing a marketplace for genomic data where individuals are incentivized to sell their data, Shivom will become a dominant market player in respect to genomic data. It will be the cause of increased supply in the market and it will be fulfilling a hidden and unaddressed demand.

The benefit of being proactive is that, for at least some time, Shivom could be the deciding factor in what direction genomic data takes. Additionally, given that Shivom has little competition or opposition, it will be acting as the market maker for a form of data that can empower research that could potentially save many lives.

Essential Links

🌐 Website: https://shivom.io/
💡 Whitepaper: https://shivom.io/files/Whitepaper.pdf
👨 ANN Thread: https://bitcointalk.org/index.php?topic=2365709.0
💻 Telegram: https://t.me/projshivom
⌚️ Token Sale: Presale Starts April 16

Connect with me:
https://bitcointalk.org/index.php?action=profile;u=1700741;sa=summary
https://steemit.com/@hatu – Follow for a new ICO analysis every day!
Twitter
Telegram Group – Keep up with ICOs